Clinical Trial: Phase 3 Study of Intravitreal 4D-150 in Adults With Diabetic Macular Edema (DME) (4D-150-C005)

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07867080) titled 'Phase 3 Study of Intravitreal 4D-150 in Adults With Diabetic Macular Edema (DME) (4D-150-C005)' on Oct. 05.

Brief Summary: A Phase 3, Randomized, Double-Masked, Active-Controlled Trial to Evaluate the Safety, Efficacy, and Durability of a Single Intravitreal Injection of 4D-150 versus Aflibercept in Adults with Diabetic Macular Edema (4SIGHT)

Study Start Date: Sept. 18

Study Type: INTERVENTIONAL

Condition: Diabetic Macular Edema (DME)

Intervention: BIOLOGICAL: 4D-150 IVT (3x10^10 vg)

If randomized to the 4D-150 treatment arm, 4D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1

BIOLO...